The Feasibility of Home Spirometry and Oximetry Monitoring In Patients With Interstitial Lung Disease - Milan 2023

New tools for risk assessment in the interstitial lung disease setting

Chair(s): Diego Castillo Villegas, Fabio Arimura

Session type: Poster session

The Feasibility of Home Spirometry and Oximetry Monitoring In Patients With Interstitial Lung Disease

Wan Lin Ng

EVENTS HOME

Poster
Abstract

Previous presentation

Next presentation

Session content

Factors prognostic of rapid progression of systemic sclerosis-associated interstitial lung disease (SSc-ILD)

Oliver Distler

Poster

Abstract

ILD progression varies in subtypes of connective tissue diseases

Phuong Phuong Diep

Poster

Abstract

Late Breaking Abstract - Characterization of high responders in the phase 2a IPF AIR trial of C21 using baseline quantitative CT image analysis

Elliott Bussell

Poster

Abstract

Late Breaking Abstract - AI-powered decision support helps pulmonologists to diagnose ILD more accurately.

Julie Maes

Poster

Abstract

Malaysian real-world data to describe progressive pulmonary fibrosis (PPF) in a clinical setting

Syazatul Syakirin Sirol Aflah

Poster

Abstract

ILD associated with systemic sclerosis: predisposing factors for progressive fibrosing ILD

Sheila Ramjug

Poster

Abstract

Interstitial lung disease in connective tissue disease: data from an Italian Multidisciplinary Unit

Alberto Bracciali

Poster

Abstract

Screening for ILD in RA: a survey of 1132 patients with RA

Anna Maria Hoffmann-vold

Poster

Abstract

Argentine registry of autoimmune interstitial lung disease: EPIMAR 2 baseline data

Juan Ignacio Enghelmayer

Poster

Abstract

Decline in BMI is a predictor of functional progression in pulmonary fibrosis associated with connective tissue disease

Alexandra Nagy

Poster

Abstract

PF-ILD and PPF criteria as predictors for mortality in RA-ILD

Phuong Phuong Diep

Poster

Abstract

The natural history of interstitial pneumonia with autoimmune features compared to connective tissue disease-associated interstitial lung disease prospective single-centre study preliminary results

Ewa Miadlikowska

Poster

Abstract

The Feasibility of Home Spirometry and Oximetry Monitoring In Patients With Interstitial Lung Disease

Wan Lin Ng

Poster

Abstract

Real world incidence & prevalence of PF-ILD in a systemic sclerosis cohort

Mahin Ahmad

Poster

Abstract

Risk factors for SSc-ILD progression using the new PPF guideline and INBUILD PF-ILD criteria

Oliver Distler

Poster

Abstract

Clinical score composite of DLCO, mMRC, and 6-mnute walking distance provides prognostic value in patients with fibrotic lung disease: A Prospective observationl Study

Pin-kuei Fu

Poster

Abstract

RA-ILD new insights into disease burden from an international patient survey

Michael Kreuter

Poster

Abstract

Living with chronic cough: experiences, burden and management in ILD a qualitative Study

Shirley Quach

Poster

Abstract

Functional improvement at one year in fibrotic interstitial lung diseases (ILD) impact of baseline biomarkers and anti-inflammatory therapies

Guangyu Shao

Poster

Abstract

Late Breaking Abstract - Inhaled pirfenidone (AP01) forced vital capacity (FVC) data from the ATLAS study vs placebo from 3 historical idiopathic pulmonary fibrosis (IPF) randomised controlled trials (RCTs)

Nazia Chaudhuri

Poster

Abstract

CDN Connection Issue

The ERS International Congress 2023, Milan

#{title}